Recent VYGR News
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/23/2024 04:31:12 PM
- Voyager Selects Tau Silencing Gene Therapy Development Candidate for Alzheimer’s Disease • GlobeNewswire Inc. • 11/20/2024 12:00:00 PM
- Voyager Reports Third Quarter 2024 Financial and Operating Results • GlobeNewswire Inc. • 11/12/2024 09:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2024 09:00:21 PM
- Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences • GlobeNewswire Inc. • 11/06/2024 12:00:00 PM
- Voyager Therapeutics Announces Third Quarter 2024 Conference Call and Webcast • GlobeNewswire Inc. • 11/05/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2024 08:43:34 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/02/2024 08:26:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2024 08:09:19 PM
- Voyager Advances Collaboration with Neurocrine; Third Gene Therapy Development Candidate Selected • GlobeNewswire Inc. • 09/16/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/05/2024 12:06:12 PM
- Voyager Enters into License for Next-Generation Capsid, Bringing Partnered Portfolio of TRACER-Enabled Gene Therapies to 14 • GlobeNewswire Inc. • 09/05/2024 12:00:00 PM
- Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 08/29/2024 08:01:00 PM
- Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences • GlobeNewswire Inc. • 08/29/2024 11:00:00 AM
- Voyager Therapeutics to Present at Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase • GlobeNewswire Inc. • 08/07/2024 11:00:00 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/06/2024 08:11:30 PM
- Voyager Therapeutics Reports Second Quarter 2024 Financial and Operating Results • GlobeNewswire Inc. • 08/06/2024 08:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 08:00:13 PM
- Voyager Therapeutics Announces Second Quarter 2024 Conference Call and Webcast • GlobeNewswire Inc. • 07/30/2024 11:00:00 AM
- Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 07/23/2024 08:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/09/2024 08:11:23 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 07/09/2024 08:10:34 PM
- Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 07/09/2024 08:01:00 PM
- Voyager Therapeutics to Present at Multiple Virtual Investor Conferences • GlobeNewswire Inc. • 06/13/2024 08:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2024 11:06:00 AM
Hertz Energy Provides Antimony and Critical Minerals Projects Update and Announces Financing • HZLIF • Dec 20, 2024 9:00 AM
North Bay Resources Announces Arrival of 42 Tons Gold Ore at Bishop Gold Mill, California • NBRI • Dec 20, 2024 9:00 AM
Consumer Automotive Finance Subsidiary Drago Knives Narrows Down Potential Partner to Manufacture Patented Throwing Knives • CAFI • Dec 20, 2024 9:00 AM
$ASNS - Is this the Next Big Cybersecurity Stock? How Actelis Networks is Revolutionizing Critical Infrastructure Protection • ASNS • Dec 20, 2024 8:50 AM
UAV Corp's (UMAV), Skyborne Technology to Build "SKY" Hangar at Its Costin Airport Scheduled for Groundbreaking Ceremony Winter 2025 • UMAV • Dec 20, 2024 8:30 AM
UAV Corp. (UMAV) Reduces Authorized Shares by 1.2 Billion, Demonstrating Commitment to Shareholders; New Authorized Share Count Approved at 800 Million • UMAV • Dec 17, 2024 12:00 PM